PPARA and chronic kidney disease: PPARa was significantly increased only in the DM_CKD group, and the other two genes (CD36 and CPT1B) showed significantly increased expression in both DM and DM_CKD groups, indicating enhanced fatty acid oxidation compared to the WT (Fig. 7a–c).